BioMarin Pharmaceutical, Inc. (BMRN)
56.58
-0.18
(-0.33%)
USD |
NASDAQ |
Jun 08, 16:00
56.58
0.00 (0.00%)
After-Hours: 17:24
BioMarin Pharmaceutical Profit Margin (Quarterly) : 13.55% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -37.60% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Incyte Corp. | 23.83% |
| Mirum Pharmaceuticals, Inc. | -494.2% |
| Cytokinetics, Inc. | -1.06K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.45% |
| Return on Assets | 3.50% |
| Return on Invested Capital | 3.94% |
| Gross Profit Margin (Quarterly) | 74.38% |
| Operating Margin (Quarterly) | 19.31% |
| Return on Net Operating Assets | 7.45% |